AJP - Heart AJP: Advances in Physiology Education
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 293: H307-H313, 2007. First published March 9, 2007; doi:10.1152/ajpheart.00789.2006
0363-6135/07 $8.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
293/1/H307    most recent
00789.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kang, S. H.
Right arrow Articles by Han, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kang, S. H.
Right arrow Articles by Han, J.

Mitochondrial Ca2+-activated K+ channels more efficiently reduce mitochondrial Ca2+ overload in rat ventricular myocytes

Sung Hyun Kang,1 Won Sun Park,1 Nari Kim,1 Jae Boum Youm,1 Mohamad Warda,1 Jae-Hong Ko,1 Eun A Ko,2 and Jin Han1

1Mitochondrial Signaling Laboratory, Mitochondria Research Group, Department of Physiology and Biophysics, College of Medicine, Biohealth Products Research Center, Cardiovascular and Metabolic Disease Research Center, Inje University, Busan, Korea; and 2Department of Medicine, University of California, San Diego, La Jolla, California

Submitted 24 July 2006 ; accepted in final form 21 February 2007


    ABSTRACT
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
We investigated the role of the mitochondrial ATP-sensitive K+ (KATP) channel, the mitochondrial big-conductance Ca2+-activated K+ (BKCa) channel, and the mitochondrial permeability transition pore (MPTP) in the ouabain-induced increase of mitochondrial Ca2+ in native rat ventricular myocytes by loading cells with rhod 2-AM. To overload mitochondrial Ca2+, we pretreated cells with ouabain before applying mitochondrial KATP or BKCa channel and/or MPTP opener. Ouabain (1 mM) increased the rhod 2-sensitive fluorescence intensity (160 ± 5.0% of control), which was dramatically decreased to the control level on application of diazoxide and NS-1619 in a dose-dependent manner (half-inhibition concentrations of 78.3 and 7.78 µM for diazoxide and NS-1619, respectively). This effect was reversed by selective inhibition of the mitochondrial KATP channel by 5-hydroxydecanoate, the mitochondrial BKCa channel by paxilline, and the MPTP by cyclosporin A. Although diazoxide did not efficiently reduce mitochondrial Ca2+ during prolonged exposure to ouabain, NS-1619 reduced mitochondrial Ca2+. These results suggest that although mitochondrial BKCa and KATP channels contribute to reduction of ouabain-induced mitochondrial Ca2+ overload, activation of the mitochondrial BKCa channel more efficiently reduces ouabain-induced mitochondrial Ca2+ overload in our experimental model.

mitochondrial BKCa channel; mitochondrial KATP channel; mitochondrial permeability transition pore; mitochondrial Ca2+; cardioprotection


MANY STUDIES HAVE SHOWN that mitochondria play a crucial role in cell survival during ischemia or ischemia-reperfusion (I/R) injury (9, 29). I/R injury leads to excessive cytosolic Ca2+, mitochondrial Ca2+ overload, and rapid increase in reactive oxygen species, which causes mitochondrial permeability transition pores (MPTPs) to open and leads to the apoptotic pathway by release of cytochrome c (13, 21, 32). For several years, sarcolemmal ATP-sensitive K+ (KATP) channels have been assumed to mediate cardioprotection against ischemia-induced heart damage, since their opening shortens the duration of the action potential and limits Ca2+ influx into cardiac cells. However, this hypothesis is not supported by research data, because the protective effect induced by an open sarcolemmal KATP channel does not always correlate with the degree of action potential shortening (6, 8, 10, 22). In contrast, opening of mitochondrial KATP and big-conductance Ca2+-activated K+ (BKCa) channels has recently been associated with increased survival of cardiac cells after ischemia. These channels have been demonstrated to be the key cytoprotective mitochondrial channels in brain, liver, skeletal muscle, and heart tissue (16, 24, 33). Therefore, mitochondrial KATP and BKCa channel openers have become the main contributors to cytoprotection against ischemia and I/R injury (9, 19). Sato et al. (25) showed that the mitochondrial KATP channel opener diazoxide attenuates ouabain-induced mitochondrial Ca2+, which is antagonized by 5-hydroxydecanoate (5-HD). Opening of the mitochondrial BKCa channel by NS-1619 also attenuates mitochondrial Ca2+ overload, with accompanying depolarization of the electrical potential, and these events are blocked by paxilline (25). Although opening of mitochondrial KATP and BKCa channels attenuates the mitochondrial Ca2+ overload independently of each other during ouabain application and modulates the different signal pathway (PKA potentiates mitochondrial BKCa channel activation, whereas PKC potentiates mitochondrial KATP channel activation), there is little evidence that the two types of channels are related, and the relative or additive effects of the two channels on the reduction of mitochondrial Ca2+ are unknown.

During I/R injury, mitochondrial Ca2+ overload occurs via Ca2+ uniporter. The developed Ca2+ gradient between the cytosol and the mitochondrial matrix can be counteracted by mitochondrial Na+/Ca2+ exchange, Ca2+ uniporter reverse mode, and the MPTP. Recent studies have proposed that the MPTP is also a candidate for mitochondrial Ca2+ modulation (2, 4, 11, 12, 15), but this mechanism is unclear.

In the present study, mitochondrial Ca2+ overload was evoked by exposure to ouabain. Elevation of cytosolic Ca2+ concentration during ischemia eventually results in mitochondrial Ca2+ accumulation. Diazoxide could decrease mitochondrial Ca2+ when the resting mitochondrial Ca2+ level is raised (17). In this study, we used the mitochondrial Ca2+-sensitive fluorescent dye rhod 2-AM to determine the role of mitochondrial KATP and/or BKCa channel openers in attenuation of ouabain-induced increase of mitochondrial Ca2+. Additionally, we used the MPTP inhibitor cyclosporin A to examine the role of the MPTP in mitochondrial Ca2+ release. This study may be the first to compare the efficiency with which mitochondrial BKCa and KATP channels reduce mitochondrial Ca2+ during short- and long-duration exposure to ouabain under the same experimental conditions.


    METHODS
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Isolation of single ventricular cardiomyocytes. All experimental procedures were reviewed and approved by the Institutional Review Board (IRB) of Animal, Inje University College of Medicine, and the procedure was carried out in accordance with the guidelines of the IRB on the ethical use of animals. Single ventricular myocytes were isolated from rat heart. At 8 wk of age, Sprague-Dawley rats (280–320 g body wt) were anesthetized by intraperitoneal injection of pentobarbital sodium (50 mg/kg body wt) and heparin (300 U/ml). The heart was rapidly removed by thoracotomy, and the aorta was cannulated. The whole heart was mounted on a Langendorff apparatus and perfused with oxygenated normal Tyrode solution at 37°C for 5–6 min to flush blood. The heart was perfused with Ca2+-free Tyrode solution for 5 min and then with Ca2+-free Tyrode solution containing 0.01% collagenase (1 mg/10 ml; Yakult) for 25–30 min and, finally, with Kraft-Brühe (KB) solution for 5–10 min. After separation of the left ventricle from the perfused heart, the single ventricular myocytes were isolated by gentle agitation in KB solution, stored at 4°C, and used within 12 h.

Solutions and drugs. Normal Tyrode solution contained (mM) 143 NaCl, 5.4 KCl, 1.8 CaCl2, 0.5 MgCl2, 5.5 glucose, and 5 HEPES, with pH adjusted to 7.4 with KOH. The modified KB solution contained (mM) 25 KCl, 10 KH2PO4, 16 KOH, 80 glutamic acid, 10 taurine, 14 oxalic acid, 10 HEPES, and 11 glucose, with pH adjusted to 7.4 with KOH.

The fluorescent dye rhod 2-AM was purchased from Molecular Probes, prepared as 1 mM stock solutions in DMSO, and diluted into test solution before each experiment. Diazoxide, 5-hydroxydecanoate (5-HD), ouabain, NS-1619, paxilline, atractyloside, and cyclosporin A were purchased from Sigma (St. Louis, MO). The final concentration of DMSO in the bath solution (<0.1%) was previously shown not to affect the recorded intensities.

Mitochondrial Ca2+ measurement. The mitochondrial Ca2+-sensitive fluorescent dye rhod 2-AM was used to trace the change in mitochondrial Ca2+. A cold-warm incubation protocol (25, 31) was used to exclusively load the mitochondria with rhod 2-AM. Briefly, myocytes were incubated with rhod 2-AM for 120 min at 4°C and then incubated for 10 min at 37°C.

Fluorescence measurement. Rhod 2-AM-loaded cells were excited at 514 nm with a neon laser, and emitted signals were collected through a 580-nm long-pass filter. Fluorescence was recorded every 10 s. Experiments were performed with a laser scanning confocal microscope (510 META, Carl Zeiss, Jena, Germany) coupled to an inverted microscope (Axiovert 200M, Carl Zeiss) with a x40 water-immersion objective lens, optimal laser lines, and filter. Cells were excited with a 514-nm argon laser, and images were acquired using a >560-nm long-pass filter. Fluorescence of rhod 2 was excited at 514 nm and emitted at 588 nm. Fluorescence was monitored every 10 s via time-series image capture. Images were digitized at eight bits and analyzed using LSM-510 META software (Carl Zeiss).

Image processing and statistical analysis. Fluorescent images were processed with LSM-510 META software, and the imaging systems enabled independent recording from several cells in the field of view. To represent changes in fluorescence intensity over time, regions of interest in the cells were outlined/highlighted, and the intensity of the chosen region in the image was calculated. In all cases, the fluorescence intensity was normalized to the initial value (F0) recorded in normal Tyrode solution and compared with the change of intensity as the relative fluorescence (F1/F0).

Experimental protocol. Rat ventricular myocytes were loaded with rhod 2-AM and then pretreated with ouabain to overload mitochondrial Ca2+. The myocytes were exposed to ouabain for ~10 min, which is the minimum time required for effective increase in mitochondrial Ca2+. In some experiments (see GoGoGoGoFigs. 5 and 6), however, duration of ouabain exposure was increased to ~30 min to more overload mitochondrial Ca2+. In this condition, mitochondrial KATP and BKCa channel and/or MPTP openers were applied.


Figure 1
View larger version (24K):
[in this window]
[in a new window]

 
Fig. 1. Effect of diazoxide on mitochondrial Ca2+ (mitoCa2+) overload in rhod 2-AM-loaded rat ventricular myocytes. A: representative recording of relative rhod 2 fluorescence intensity (F1/F0) from a single myocyte. Ouabain (OUA, 1 mM), diazoxide (DIA, 100 µM), and 5-hydroxydecanoate (5-HD, 500 µM) were applied as indicated by horizontal bars. B: confocal images of rhod 2 fluorescence before (a) and after treatment with ouabain (b), ouabain + diazoxide (c), and ouabain + diazoxide + 5-HD (d). Scale bar, 20 µm. C: summary of changes in rhod 2 fluorescence intensity before (control) and after treatment with ouabain, diazoxide, and 5-HD. *P < 0.05 vs. control. {ddagger}P < 0.05 vs. ouabain. #P < 0.05 vs. ouabain + diazoxide. D: concentration-response curve for effect of diazoxide on ouabain-induced mitochondrial Ca2+ overload. Hill's equation was used for curve fitting.

 

Figure 2
View larger version (27K):
[in this window]
[in a new window]

 
Fig. 2. Effect of NS-1619 on mitochondrial Ca2+ overload in rat ventricular myocytes. A: representative recording of relative rhod 2 fluorescence from a single myocyte before (a) and after application of 1 mM ouabain (b), ouabain + NS-1619 (c), and ouabain + NS-1619 + paxilline (d). B: confocal images of rhod 2 fluorescence for corresponding arrowheads in A. Scale bar, 20 µm. C: summary of changes in rhod 2 fluorescence intensity before (control) and after treatment with ouabain, NS-1619, and paxilline. *P < 0.05 vs. control. {ddagger}P < 0.05 vs. OUA. #P < 0.05 vs. OUA + NS-1619. D: concentration-response curve for effect of NS-1619 on ouabain-induced mitochondrial Ca2+ overload. Hill's equation was used for curve fitting.

 

Figure 3
View larger version (28K):
[in this window]
[in a new window]

 
Fig. 3. Effect of cyclosporin A on mitochondrial Ca2+ overload with diazoxide and NS-1619 in rhod 2-AM-loaded rat ventricular myocytes. A: representative recording of relative rhod 2 fluorescence intensity from a single myocyte before (control) and after treatment with 1 mM ouabain, 100 µM diazoxide, and 2 µM cyclosporin A (CysA). B: confocal image of rhod 2 fluorescence for corresponding arrowheads in A. Scale bar, 20 µm. C: summary of changes in rhod 2 fluorescence intensity of A (n = 6). Horizontal bar, 20 µm. D: representative recording of relative rhod 2 fluorescence intensity from a single myocyte before (control) and after treatment with ouabain, NS-1619, and cyclosporin A. E: confocal image of rhod 2 fluorescence for corresponding arrowheads in D. Scale bar, 20 µm. F: summary of changes in rhod 2 fluorescence intensity in D (n = 6). *P < 0.05 vs. control. {ddagger}P < 0.05 vs. OUA. #P < 0.05 vs. OUA + DIA or OUA + NS.

 

Figure 4
View larger version (11K):
[in this window]
[in a new window]

 
Fig. 4. Effect of atractyloside on mitochondrial Ca2+ overload in rhod 2-AM-loaded rat ventricular myocytes. A: representative recording of relative rhod 2 fluorescence intensity from single myocyte before (control) and after treatment with ouabain, atractyloside, and cyclosporin A. B: confocal image of rhod 2 fluorescence for corresponding arrowheads in A. Scale bar, 20 µm. C: summarized of changes in rhod 2 fluorescence intensity in A (n = 6). *P < 0.05 vs. control. {ddagger}P < 0.05 vs. OUA. #P < 0.05 vs. OUA + atractyloside.

 

Figure 5
View larger version (19K):
[in this window]
[in a new window]

 
Fig. 5. Effect of diazoxide and NS-1619 on mitochondrial Ca2+ overload with prolonged exposure to ouabain. A and C: representative recordings of relative rhod 2 fluorescence intensity in a single myocyte. Ouabain (1 mM), diazoxide (100 µM), and NS-1619 (NS, 10 µM) were applied as indicated on horizontal bars. B and D: summaries of A and C, respectively. *P < 0.05 vs. control. {ddagger}P < 0.05 vs. DIA or NS.

 

Figure 6
View larger version (23K):
[in this window]
[in a new window]

 
Fig. 6. Effect of diazoxide, NS-1619, and cyclosporin A on mitochondrial Ca2+ overload. A and C: representative recording of rhod 2 fluorescence intensity in a single ventricular myocyte. B and D: summaries of A and C, respectively. *P < 0.05 vs. control. {ddagger}P < 0.05 vs. OUA. #P < 0.05 vs. OUA + NS. {blacklozenge}P < 0.05 vs. OUA + DIA + NS, or OUA + NS + DIA.

 
Statistical analysis. Values are means ± SE. Statistical significance was estimated by one-way ANOVA and Student Newman-Keuls test for comparison of several groups. Differences were considered significant at P < 0.05.


    RESULTS
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Mitochondrial KATP channel opening attenuates overloaded mitochondrial Ca2+. Rat ventricular myocytes were loaded with the mitochondrial Ca2+-selective fluorescent dye rhod 2-AM, and mitochondrial Ca2+ was monitored by confocal microscopy. The Na+-K+-ATPase inhibitor ouabain was used to produce mitochondrial Ca2+ overload. Application of 1 mM ouabain increased the rhod 2-sensitive fluorescence intensity within 12 ± 3 min (n = 10): 1.03 ± 0.02 and 1.62 ± 0.05 F1/F0 for control and ouabain, respectively (Fig. 1A). Application of 100 µM diazoxide dramatically decreased ouabain-induced mitochondrial Ca2+ overload to control level (Fig. 1A). Subsequent addition of the selective mitochondrial KATP channel inhibitor 5-HD (500 µM) (18) reversed the attenuation effect of diazoxide on ouabain-induced mitochondrial Ca2+ overload, suggesting that opening of the mitochondrial KATP channel reduced the ouabain-sensitive mitochondrial Ca2+ overload. Attenuation of ouabain-induced mitochondrial Ca2+ is dependent on the dose of diazoxide (Fig. 1D): in the presence of 30, 60, 100, and 300 µM diazoxide, relative fluorescence intensity (F1/F0) of rhod 2 evoked by 1 mM ouabain (2.40 ± 0.12) decreased to 2.28 ± 0.11 (n = 6), 2.07 ± 0.10 (n = 6), 1.31 ± 0.07 (n = 8), and 0.97 ± 0.05 (n = 10), respectively. Diazoxide attenuated the ouabain-induced mitochondrial Ca2+ overload at a half-inhibition concentration of 78.3 ± 3.36 µM.

Mitochondrial BKCa channel opening attenuates mitochondrial Ca2+ overload. To test the role of the mitochondrial BKCa channel in mitochondrial Ca2+ overload, we applied the specific mitochondrial BKCa channel agonist 1-(2'-hydroxy-5'-trifluoromethylphenyl)-5-trifluoromethyl-2(3H) benzimid-axolone (NS-1619) to freshly isolated rat ventricular myocytes loaded with rhod 2-AM. After 10 min of ouabain-induced mitochondrial Ca2+ overload (0.90 ± 0.05 and 1.77 ± 0.12 F1/F0 for control and ouabain, respectively, n = 8), mitochondrial Ca2+ overload was reduced (0.99 ± 0.05 F1/F0) by 10 µM NS-1619 (Fig. 2, A and C). The NS-1619-induced reduction of mitochondrial Ca2+ was reversed by 2 µM paxilline. Attenuation of ouabain-induced mitochondrial Ca2+ was dependent on the dose of NS-1619 (Fig. 2D): in the absence of NS-1619 (ouabain alone), the relative increase in rhod 2 fluorescence intensity (F1/F0) was 2.40 ± 0.11 of control (n = 15); however, it decreased to 2.28 ± 0.11 (n = 3), 2.07 ± 0.10 (n = 3), and 1.31 ± 0.07 (n = 7) in the presence of 2, 6, and 10 µM NS-1619, respectively. The half-inhibition concentration of NS-1619 for attenuation of ouabain-induced mitochondrial Ca2+ overload was 7.78 ± 0.44 µM.

Role of MPTPs in efflux of mitochondrial Ca2+. The role of the MPTPs in ouabain-induced mitochondrial Ca2+ overload was evaluated by the MPTP blocker cyclosporin A and the MPTP opener atractyloside. After blockade of ouabain-induced mitochondrial Ca2+ overload with 100 µM diazoxide (Fig. 3, A–C) or 10 µM NS-1619 (Fig. 3, D–F), the cells were treated with cyclosporin A. Ouabain-induced mitochondrial Ca2+ overload was suppressed by diazoxide and NS-1619, which was antagonized by cyclosporin A (Fig. 3, A and D). To investigate the direct role of MPTPs in ouabain-induced mitochondrial Ca2+ overload, we applied 20 µM atractyloside. After ouabain-induced mitochondrial Ca2+ overload (1.05 ± 0.01 and 2.25 ± 0.11 F1/F0 for control and ouabain, respectively), direct opening of MPTPs induced by atractyloside attenuated the ouabain-induced mitochondrial Ca2+ overload (1.64 ± 0.09 F1/F0, n = 8), which was antagonized by cyclosporin A (Fig. 4A).

Comparison of the attenuation effect on mitochondrial Ca2+ overload between mitochondrial KATP and BKCa channels during prolonged exposure to ouabain. To evaluate the efficacy of mitochondrial KATP and BKCa channels during prolonged mitochondrial Ca2+ overload (extended exposure to ouabain), single rat ventricular myocytes loaded with rhod 2-AM were exposed to 1 mM ouabain for 30 ± 5 min. The rhod 2 fluorescence intensity (F1/F0) increased to 2.67 ± 0.03 (Fig. 5A) and 2.92 ± 0.11 (Fig. 5C), respectively. Half-inhibition concentrations of diazoxide and NS-1619 decreased mitochondrial Ca2+ overload to 2.21 ± 0.15 (Fig. 5B; n = 7) and 1.57 ± 0.09 F1/F0 (Fig. 5D; n = 9), respectively.

Additive effect of mitochondrial KATP and BKCa channels and MPTPs on mitochondrial Ca2+ efflux during prolonged mitochondrial Ca2+ overload. When cells were exposed to ouabain for an extended time (30 ± 5 min), it was difficult to lower the mitochondrial Ca2+ overload to the control value with 100 µM diazoxide alone (Fig. 5A). Although NS-1619 reduced the mitochondrial Ca2+ overload by ~60%, NS-1619 did not completely lower mitochondrial Ca2+ to control level. However, when prolonged ouabain-induced mitochondrial Ca2+ overload was treated with diazoxide + NS-1619, mitochondrial Ca2+ was effectively reduced to control level. Diazoxide could not attenuate the prolonged mitochondrial Ca2+ overload by ouabain (Fig. 6A), whereas subsequent application of NS-1619 significantly reduced the prolonged ouabain-induced increase in mitochondrial Ca2+ (Fig. 6B; n = 6). Furthermore, NS-1619 alone lowered the prolonged ouabain-induced increase in mitochondrial Ca2+ by ~60%. However, subsequent application of diazoxide reduced the mitochondrial Ca2+ to control level (Fig. 6C; n = 8). The attenuation effect of diazoxide + NS-1619 or NS-1619 + diazoxide on prolonged ouabain-induced mitochondrial Ca2+ overload was reversed by cyclosporin A (Fig. 6, B and D). These results suggest that the mitochondrial BKCa channel more efficiently attenuates mitochondrial Ca2+ than the mitochondrial KATP channel during the prolonged mitochondrial Ca2+ overload.


    DISCUSSION
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
KATP channel opening in inner mitochondrial membranes protects hearts from I/R injury. Opening of the BKCa channel is also known to elicit cardiac preconditioning. We investigated the role of pharmacological opening of these channels on the ouabain-induced mitochondrial Ca2+ overload. The mitochondrial KATP channel opener diazoxide and the mitochondrial BKCa channel opener NS-1619 attenuated the early phase of ouabain-induced mitochondrial Ca2+ overload. The data revealed that mitochondrial BKCa channel opening more efficiently attenuates mitochondrial Ca2+ than mitochondrial KATP channel opening during prolonged exposure to an ouabain-induced increase in mitochondrial Ca2+.

During the early stage of mitochondrial Ca2+ overload evoked by 1 mM ouabain, an attenuation effect was induced by both openers. This attenuation, however, was blocked by their specific blockers: the mitochondrial KATP channel blocker 5-HD and the mitochondrial BKCa channel blocker paxilline. Our results support the suggestion that opening of the two mitochondrial K+ channel isoforms can prevent ischemia- or I/R injury-induced mitochondrial Ca2+ overload. Each of the mitochondrial K+ openers showed dose-dependent responses. The mitochondrial BKCa channel opener NS-1619 exhibited a high efficacy for mitochondrial Ca2+ attenuation and a sensitive response before diazoxide administration during the early stage or with prolonged exposure to ouabain. O'Rourke et al. (23) also proposed that the mitochondrial BKCa channel might be activated at high mitochondrial Ca2+ loads, acting as a relief valve to prevent further Ca2+ accumulation.

Recently, mitochondrial KATP and BKCa channels have been proposed as cytoprotective mitochondrial channels. The mitochondrial KATP channel was first identified by Inoue et al. (16). The conductance of the channel was recorded to be 9.7 ± 1.0 pS with 100 mM K+ pipette solution and 33.3 mM K+ bathing solution. Diazoxide, nicorandil, and BMS-191095 selectively open mitochondrial KATP channels, with minimal effects on the cardiac isoform sarclemmal KATP channel, whereas other K+ channel openers, including cromakalim, EMD-60480, EMD-57970, pinacidil, RP-66471, minoxidil sulfate, and KRN-2391, nonselectively activate mitochondrial and sarcolemmal KATP channels. In the case of mitochondrial KATP channel blockers, glibenclamide and glipizide antagonize both isoforms, whereas 5-HD and MCC-134 selectively inhibit the mitochondrial KATP channel, with little effect on the sarcolemmal KATP channel (1, 3, 7, 30). The mitochondrial BKCa channel was first demonstrated by Siemen et al. (27). Using a patch-clamp technique in mitoplasts of the human glioma cell line LN 229, they recorded a K+-selective channel showing a conductance of 295 ± 18 pS. Xu et al. (33) first showed the presence of the mitochondrial BKCa channel in cardiomyocytes. They also recorded single-channel currents (307 ± 4.6 pS) in mitoplasts from cardiac myocytes. The channel was activated by 512 nM Ca2+ and inhibited by 200 nM charybdotoxin. Mitochondrial BKCa channel opening led to K+ influx into the mitochondrial matrix; this event was activated by NS-1619 and valinomycin and antagonized by charybdotoxin. Although the mechanism is unclear, several investigators proposed that opening of mitochondrial KATP and BKCa channels functions as a trigger or mediator in ischemia-preconditioning (IPC). Some investigators have shown that diazoxide (5) and NS-1619 (28) trigger the protective effect of IPC and that these events are antagonized by 5-HD and paxilline, respectively. Furthermore, the MPTP is a large nonselective channel that plays a role in the apoptotic pathway by releasing cytochrome c from the intermembrane space (4). Hausenloy et al. (14) showed that transient opening of MPTPs (low-conductance) during diazoxide-induced IPC may play a role in cell survival and that this cytoprotection of IPC is abolished by the MPTP inhibitor cyclosporin A or by reactive oxygen species scavengers. Recently, several reports showed that MPTP opening mediates depolarization, Ca2+ efflux from mitochondria, and cardioprotection (20, 26). Consistent with these reports, our results also showed that opening of MPTPs reduced ouabain-induced mitochondrial Ca2+ overload.

The present investigation was intended to connect the mitochondrial Ca2+ attenuation effect of two mitochondrial K+ channel isoforms with the MPTP during ouabain-induced mitochondrial Ca2+ overload. Although we cannot confirm the cardioprotective effect of MPTPs on mitochondrial Ca2+ overload, the involvement of these nonselective ion channels in mitochondrial Ca2+ reduction during ouabain-induced mitochondrial Ca2+ overload might indicate MPTP-mediated cardioprotection.


    GRANTS
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
This work was supported by Korea Research Foundation Grants KRF-2005-210-E00003, KRF-2005-211-E00006, KRF-2005-037-E00002, KRF-2005-042-E00010, KRF-2006-521-E00013, KRF-2006-312-E00018, and KRF-2006-312-C00601 funded by the Korean Government.


    FOOTNOTES
 

Address for reprint requests and other correspondence: J. Han, Mitochondrial Signaling Laboratory, Dept. of Physiology and Biophysics, College of Medicine, Biohealth Products Research Center, Cardiovascular and Metabolic Disease Research Center, Inje Univ. 633-165 Gaegeum-Dong, Busanjin-Gu, Busan 613-735, Korea (e-mail: phyhanj{at}ijnc.inje.ac.kr)

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.


    REFERENCES
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 

  1. Ardehali H, O'Rourke B. Mitochondrial KATP channels in cell survival and death. J Mol Cell Cardiol 39: 7–16, 2005.[CrossRef][Web of Science][Medline]
  2. Bernardi P. Mitochondrial transport of cations: channels, exchangers, and permeability transition. Physiol Rev 79: 1127–1155, 1999.[Abstract/Free Full Text]
  3. Costa ADT, Quinlan CL, Andrukhiv A, West IC, Jaburek M, Garlid KD. The direct physiological effects of mitoKATP opening on heart mitochondria. Am J Physiol Heart Circ Physiol 290: H406–H415, 2006.[Abstract/Free Full Text]
  4. Crompton M. The mitochondrial permeability transition pore and its role in cell death. Biochem J 341: 233–249, 1999.[CrossRef][Web of Science][Medline]
  5. Das DK, Maulik N, Sato M, Ray PS. Reactive oxygen species function as second messenger during ischemic preconditioning of heart. Mol Cell Biochem 196: 59–67, 1999.[CrossRef][Web of Science][Medline]
  6. Delcamp TJ, Dales C, Ralenkotter L, Cole PS, Hadley RW. Intramitochondrial [Ca2+] and membrane potential in ventricular myocytes exposed to anoxia-reoxygenation. Am J Physiol Heart Circ Physiol 275: H484–H494, 1998.[Abstract/Free Full Text]
  7. Garlid KD. Opening mitochondrial KATP in the heart—what happens, and what does not happen. Basic Res Cardiol 95: 275–279, 2000.[CrossRef][Web of Science][Medline]
  8. Grover GJ, D'Alonzo AJ, Garlid KD, Bajgar R, Lodge NJ, Sleph PG, Darbenzio RB, Hess TA, Smith MA, Paucek P, Atwal KS. Pharmacologic characterization of BMS-191095, a mitochondrial KATP opener with no peripheral vasodilator or cardiac action potential shortening activity. J Pharmacol Exp Ther 297: 1184–1192, 2001.[Abstract/Free Full Text]
  9. Grover GJ, Garlid KD. ATP-sensitive potassium channels: a review of their cardioprotective pharmacology. J Mol Cell Cardiol 32: 677–695, 2000.[CrossRef][Web of Science][Medline]
  10. Grover GJ, D'Alonzo AJ, Hess T, Sleph PG, Darbenzio RB. Glyburide-reversible cardioprotective effect of BMS-180448 is independent of action potential shortening. Cardiovasc Res 30: 731–738, 1995.[CrossRef][Web of Science][Medline]
  11. Gunter TE, Buntinas L, Sparagna G, Eliseev R, Gunter K. Mitochondrial calcium transport: mechanisms and functions. Cell Calcium 28: 285–296, 2000.[CrossRef][Web of Science][Medline]
  12. Gunter TE, Gunter KK, Sheu SS, Gavin CE. Mitochondrial calcium transport: physiological and pathological relevance. Am J Physiol Cell Physiol 267: C313–C339, 1994.[Abstract/Free Full Text]
  13. Halestrap AP. The mitochondrial permeability transition: its molecular mechanism and role in reperfusion injury. Biochem Soc Symp 66: 181–203, 1999.[Medline]
  14. Hausenloy D, Wynne A, Duchen M, Yellon D. Transient mitochondrial permeability transition pore opening mediates preconditioning-induced protection. Circulation 109: 1714–1717, 2004.[Abstract/Free Full Text]
  15. Ichas F, Mazat JP. From calcium signaling to cell death: two conformations for the mitochondrial permeability transition pore. Switching from low- to high-conductance state. Biochim Biophys Acta 1366: 33–50, 1998.[Medline]
  16. Inoue I, Nagase H, Kishi K, Higuti T. ATP-sensitive K+ channel in the mitochondrial inner membrane. Nature 352: 244–247, 1991.[CrossRef][Medline]
  17. Ishida H, Hirota Y, Genka C, Nakazawa H, Nakaya H, Sato T. Opening of mitochondrial KATP channels attenuates the ouabain-induced calcium overload in mitochondria. Circ Res 89: 856–858, 2001.[Abstract/Free Full Text]
  18. Jaburek M, Yarov-Yarovoy V, Paucek P, Garlid KD. State-dependent inhibition of the mitochondrial KATP channel by glyburide and 5-hydroxydecanoate. J Biol Chem 273: 13578–13582, 1998.[Abstract/Free Full Text]
  19. Jahangir A, Terzic A. KATP channel therapeutics at the bedside. J Mol Cell Cardiol 39: 99–112, 2005.[CrossRef][Web of Science][Medline]
  20. Katoh H, Nishigaki N, Hayashi H. Diazoxide opens the mitochondrial permeability transition pore and alters Ca2+ transients in rat ventricular myocytes. Circulation 105: 2666–2671, 2002.[Abstract/Free Full Text]
  21. Lemasters JJ, Nieminen AL, Qian T, Trost LC, Elmore SP, Nishimura Y, Crowe RA, Cascio WE, Bradham CA, Brenner DA, Herman B. The mitochondrial permeability transition in cell death: a common mechanism in necrosis, apoptosis and autophagy. Biochim Biophys Acta 1366: 177–196, 1998.[Medline]
  22. Liu Y, Sato T, O'Rourke B, Marban E. Mitochondrial ATP-dependent potassium channels. Novel effectors of cardioprotection? Circulation 97: 2463–2469, 1998.[Abstract/Free Full Text]
  23. O'Rourke B, Cortassa S, Aon MA. Mitochondrial ion channels: gatekeepers of life and death physiology. J Physiol 20: 303–315, 2005.[CrossRef]
  24. Paucek P, Mironova G, Mahdi F, Beavis AD, Woldegiorgis G, Garlid KD. Reconstitution and partial purification of the glibenclamide-sensitive, ATP-dependent K+ channel from rat liver and beef heart mitochondria. J Biol Chem 267: 26062–26069, 1992.[Abstract/Free Full Text]
  25. Sato T, Saito T, Saegusa N, Nakaya H. Mitochondrial Ca2+-activated K+ channels in cardiac myocytes: a mechanism of the cardioprotective effect and modulation by protein kinase A. Circulation 111: 198–203, 2005.[Abstract/Free Full Text]
  26. Shanmuganathan S, Hausenloy DJ, Duchen MR, Yellon DM. Mitochondrial permeability transition pore as a target for cardioprotection in the human heart. Am J Physiol Heart Circ Physiol 289: H237–H242, 2005.[Abstract/Free Full Text]
  27. Siemen D, Loupatatzis C, Borecky J, Gulbins E, Lang F. Ca2+-activated K channel of the BK type in the inner mitochondrial membrane of a human glioma cell line. Biochem Biophys Res Commun 257: 549–554, 1999.[CrossRef][Web of Science][Medline]
  28. Stowe DF, Aldakkak M, Camara AKS, Riess ML, Heinen A, Varadarajan SG, Jiang MT. Cardiac mitochondrial preconditioning by big Ca2+-sensitive K+ channel opening requires superoxide radical generation. Am J Physiol Heart Circ Physiol 290: H434–H440, 2006.[Abstract/Free Full Text]
  29. Suleiman MS, Halestrap AP, Griffiths EJ. Mitochondria: a target for myocardial protection. Pharmacol Ther 89: 29–46, 2001.[CrossRef][Web of Science][Medline]
  30. Tian J, Liu J, Garlid KD, Shapiro JI, Xie Z. Involvement of mitogen-activated protein kinases and reactive oxygen species in the inotropic action of ouabain on cardiac myocytes. A potential role for mitochondrial KATP channels. Mol Cell Biochem 242: 181–187, 2003.[CrossRef][Web of Science][Medline]
  31. Trollinger DR, Cascio WE, Lemasters JJ. Mitochondrial calcium transients in adult rabbit cardiac myocytes: inhibition by ruthenium red and artifacts caused by lysosomal loading of Ca2+-indicating fluorophores. Biophys J 79: 39–50, 2000.[Web of Science][Medline]
  32. Weiss JN, Korge P, Honda HM, Ping P. Role of the mitochondrial permeability transition in myocardial disease. Circ Res 93: 292–301, 2003.[Abstract/Free Full Text]
  33. Xu W, Liu Y, Wang S, McDonald T, Van Eyk JE, Sidor A, O'Rourke B. Cytoprotective role of Ca2+-activated K+ channels in cardiac inner mitochondrial membrane. Science 298: 895–902, 2002.




This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
293/1/H307    most recent
00789.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kang, S. H.
Right arrow Articles by Han, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kang, S. H.
Right arrow Articles by Han, J.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.